RH-35 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Rat cell lines

Organism

Rat

Donor History

Rat hepatocellular carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: Ham's F12

,

w: 1.0 mM stable Glutamine

,

w: 1.0 mM Sodium pyruvate

,

w: 1.1 g/L NaHCO3 (Cytion article number 820600a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/RH-35-Cells/305210

SKU: 305210 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The H4-II-E (also referred to as RH-35) cell line is a derivative of the Reuber H-35 rat hepatoma. This cell line originated from a liver tumor induced in a male ACI rat by exposure to the chemical carcinogen N-2-fluorenyldiacetamide. When transplanted into ACI rats, H4-II-E cells form rapidly growing tumors with histological features characteristic of poorly differentiated hepatomas. They are particularly sensitive to the induction of aryl hydrocarbon hydroxylase (AHH) activity, making them a robust system for studying enzymatic responses to polycyclic aromatic hydrocarbons and dioxin-like compounds.

H4-II-E cells also serve as a model for studying cellular responses to carcinogens and radiation, given their clonogenicity and the ability to assay long-term cell survival post-treatment. Their application extends to exploring the mechanisms of enzyme induction, xenobiotic metabolism, and liver-specific toxicology. These attributes make H4-II-E an invaluable tool in cancer research and toxicological screening.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.